{"id":"W4285992688","doi":"10.1016/j.jid.2022.05.316","title":"308 Incremental improvements after switching from dupilumab (DUPI) to upadacitinib (UPA) in the Heads Up open-label extension (OLE) study","year":2022,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research; University of Calgary","funders":"","keywords":"Eczema Area and Severity Index; Atopic dermatitis; Medicine; Dupilumab; Open label; Internal medicine; Randomized controlled trial; Dermatology; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002190092,0.0009383829,0.002003447,0.0002737162,0.0003371321,0.001318142,0.0003735927,0.0008707374,0.005523735],"category_scores_gemma":[0.003078338,0.0002873018,0.003546753,0.0004077091,0.0004278227,0.001159756,0.0003455495,0.002962916,0.001078664],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006969387,"about_ca_system_score_gemma":0.0006792257,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009821857,"about_ca_topic_score_gemma":0.001631896,"domain_scores_codex":[0.9989838,0.0003972373,0.00008415399,0.0001840639,0.0001207676,0.0002299371],"domain_scores_gemma":[0.9979824,0.0009243995,0.0003617768,0.0001576895,0.0001915292,0.0003821696],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8599105,0.00418185,0.01091656,0.0009784866,0.004413591,0.0001853299,0.000106807,0.000935118,0.003824321,0.0001453684,0.002718346,0.1116837],"study_design_scores_gemma":[0.3912596,0.3198391,0.2388846,0.0007921796,0.0267952,0.0007283108,0.000381968,0.003161919,0.005538858,0.001190208,0.01123301,0.0001951499],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9830914,0.008229442,0.0003949755,0.0005058515,0.000516528,0.0003897953,0.003127243,0.00008225386,0.003662552],"genre_scores_gemma":[0.9943277,0.001405596,0.0003753703,0.0004925375,0.000209016,0.0001628547,0.002001158,0.00001119379,0.00101467],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005523735,"threshold_uncertainty_score":0.01847875,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05914826964645313,"score_gpt":0.3492673664943894,"score_spread":0.2901190968479362,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}